Skip to main content

MoneyWorks4Me

The sales for the September 2026 quarter moved up 38.08% to Rs. 2418.80 millions as compared to Rs. 1751.80 millions during the corresponding quarter last year.Good  Net Profit growth of 27.22% reported above the corresponding previous quarter figure of Rs. 1025.90 millions to Rs. 1305.10 millioins.The company reported a good operating profit of 1741.80 millions compared to 1350.70 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 2418.80 1751.80 38.08 4448.30 3577.50 24.34 7383.30 7524.10 -1.87
Other Income 510.40 592.20 -13.81 1138.30 912.50 24.75 1953.70 1345.90 45.16
PBIDT 1741.80 1350.70 28.96 3313.80 2537.10 30.61 5331.50 4665.60 14.27
Interest 0.60 0.50 20.00 1.10 0.90 22.22 2.00 1.20 66.67
PBDT 1741.20 1350.20 28.96 3312.70 2536.20 30.62 5329.50 4664.40 14.26
Depreciation 70.70 60.20 17.44 136.30 121.60 12.09 254.30 247.70 2.66
PBT 1670.50 1290.00 29.50 3176.40 2414.60 31.55 5075.20 4416.70 14.91
TAX 365.40 264.10 38.36 667.50 529.80 25.99 1109.40 1021.80 8.57
Deferred Tax -2.50 -3.60 -30.56 12.00 -7.00 -271.43 14.50 -7.20 -301.39
PAT 1305.10 1025.90 27.22 2508.90 1884.80 33.11 3965.80 3394.90 16.82
Equity 152.00 152.00 0.00 152.00 152.00 0.00 152.00 152.00 0.00
PBIDTM(%) 72.01 77.10 -6.60 74.50 70.92 5.04 72.21 62.01 16.45
Peers
Company Name CMP
Sun Pharma. Inds. 1894.90
Dr. Reddys Labs. 1391.10
Cipla 1409.75
Lupin 1985.85
Zydus Lifesciences 1192.00
View more..